Karin Gehring1,2, Corelien Jj Kloek1,3, Neil K Aaronson4, Kasper W Janssen5, Lee W Jones6, Margriet M Sitskoorn1, Martijn M Stuiver7,8. 1. 1 Department of Cognitive Neuropsychology, Tilburg University, Tilburg, The Netherlands. 2. 2 Department of Neurosurgery, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands. 3. 3 Research Group of Innovation of Human Movement Care, University of Applied Sciences Utrecht, Utrecht, The Netherlands. 4. 4 Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. 5. 5 Department of Sports and Exercise Medicine, Gelderse Vallei Hospital, Ede, The Netherlands. 6. 6 Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 7. 7 Department of Physical Therapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands. 8. 8 ACHIEVE, Faculty of Health, University of Applied Sciences Amsterdam, Amsterdam, The Netherlands.
Abstract
OBJECTIVE: In this pilot study, we investigated the feasibility of a home-based, remotely guided exercise intervention for patients with gliomas. DESIGN: Pilot randomized controlled trial (RCT) with randomization (2:1) to exercise or control group. SUBJECTS:Patients with stable grade II and III gliomas. INTERVENTION: The six-month intervention included three home-based exercise sessions per week at 60%-85% of maximum heart rate. Participants wore heart rate monitors connected to an online platform to record activities that were monitored weekly by the physiotherapist. MAIN MEASURES: Accrual, attrition, adherence, safety, satisfaction, patient-reported physical activity, VO2 peak (by maximal cardiopulmonary exercise testing) and body mass index (BMI) at baseline and at six-month follow-up. RESULTS: In all, 34 of 136 eligible patients (25%) were randomized to exercise training ( N = 23) or the control group ( N = 11), of whom 19 and 9, respectively, underwent follow-up. Mean adherence to prescribed sessions was 79%. Patients' experiences were positive. There were no adverse events. Compared to the control group, the exercise group showed larger improvements in absolute VO2 peak (+158.9 mL/min; 95% CI: -44.8 to 362.5) and BMI (-0.3 kg/m²; 95% CI: -0.9 to 0.2). The median increase in physical activity was 1489 metabolic equivalent of task (MET) minutes higher in the exercise group. The most reported reasons for non-participation were lack of motivation or time. CONCLUSION: This innovative and intensive home-based exercise intervention was feasible in a small subset of patients with stable gliomas who were interested in exercising. The observed effects suggest that the programme may improve cardiorespiratory fitness. These results support the need for large-scale trials of exercise interventions in brain tumour patients.
RCT Entities:
OBJECTIVE: In this pilot study, we investigated the feasibility of a home-based, remotely guided exercise intervention for patients with gliomas. DESIGN: Pilot randomized controlled trial (RCT) with randomization (2:1) to exercise or control group. SUBJECTS:Patients with stable grade II and III gliomas. INTERVENTION: The six-month intervention included three home-based exercise sessions per week at 60%-85% of maximum heart rate. Participants wore heart rate monitors connected to an online platform to record activities that were monitored weekly by the physiotherapist. MAIN MEASURES: Accrual, attrition, adherence, safety, satisfaction, patient-reported physical activity, VO2 peak (by maximal cardiopulmonary exercise testing) and body mass index (BMI) at baseline and at six-month follow-up. RESULTS: In all, 34 of 136 eligible patients (25%) were randomized to exercise training ( N = 23) or the control group ( N = 11), of whom 19 and 9, respectively, underwent follow-up. Mean adherence to prescribed sessions was 79%. Patients' experiences were positive. There were no adverse events. Compared to the control group, the exercise group showed larger improvements in absolute VO2 peak (+158.9 mL/min; 95% CI: -44.8 to 362.5) and BMI (-0.3 kg/m²; 95% CI: -0.9 to 0.2). The median increase in physical activity was 1489 metabolic equivalent of task (MET) minutes higher in the exercise group. The most reported reasons for non-participation were lack of motivation or time. CONCLUSION: This innovative and intensive home-based exercise intervention was feasible in a small subset of patients with stable gliomas who were interested in exercising. The observed effects suggest that the programme may improve cardiorespiratory fitness. These results support the need for large-scale trials of exercise interventions in brain tumourpatients.
Entities:
Keywords:
Glioma; brain tumour; exercise; physical fitness; physical training
Authors: Cora L Craig; Alison L Marshall; Michael Sjöström; Adrian E Bauman; Michael L Booth; Barbara E Ainsworth; Michael Pratt; Ulf Ekelund; Agneta Yngve; James F Sallis; Pekka Oja Journal: Med Sci Sports Exerc Date: 2003-08 Impact factor: 5.411
Authors: Lee W Jones; Bebe Guill; Stephen T Keir; Karen Carter; Henry S Friedman; Darell D Bigner; David A Reardon Journal: Support Care Cancer Date: 2006-07-04 Impact factor: 3.603
Authors: Karin Gehring; Margriet M Sitskoorn; Chad M Gundy; Sietske A M Sikkes; Martin Klein; Tjeerd J Postma; Martin J van den Bent; Guus N Beute; Roelien H Enting; Arnoud C Kappelle; Willem Boogerd; Theo Veninga; Albert Twijnstra; Dolf H Boerman; Martin J B Taphoorn; Neil K Aaronson Journal: J Clin Oncol Date: 2009-05-26 Impact factor: 44.544
Authors: Liza van Deursen; Anke Versluis; Rosalie van der Vaart; Lucille Standaar; Jeroen Struijs; Niels Chavannes; Jiska J Aardoom Journal: JMIR Cancer Date: 2022-06-14
Authors: Jessica M Scott; Emily C Zabor; Emily Schwitzer; Graeme J Koelwyn; Scott C Adams; Tormod S Nilsen; Chaya S Moskowitz; Konstantina Matsoukas; Neil M Iyengar; Chau T Dang; Lee W Jones Journal: J Clin Oncol Date: 2018-06-12 Impact factor: 44.544
Authors: Pearl J C van Lonkhuizen; Kete M Klaver; Jeffrey S Wefel; Margriet M Sitskoorn; Sanne B Schagen; Karin Gehring Journal: Eur J Cancer Care (Engl) Date: 2019-05-14 Impact factor: 2.328
Authors: Rebecca R Turner; Liz Steed; Helen Quirk; Rosa U Greasley; John M Saxton; Stephanie Jc Taylor; Derek J Rosario; Mohamed A Thaha; Liam Bourke Journal: Cochrane Database Syst Rev Date: 2018-09-19
Authors: Karin Gehring; Martijn M Stuiver; Eva Visser; Corelien Kloek; Martin van den Bent; Monique Hanse; Cees Tijssen; Geert-Jan Rutten; Martin J B Taphoorn; Neil K Aaronson; Margriet M Sitskoorn Journal: Neuro Oncol Date: 2020-01-11 Impact factor: 12.300